Cargando…
Prevalence of SARS-CoV-2 in Pregnant Women Assessed by RT-PCR in Franconia, Germany: First Results of the SCENARIO Study (SARS-CoV-2 prEvalence in pregNAncy and at biRth In FrancOnia)
Purpose Detection of SARS-CoV-2-infected pregnant women admitted to maternity units during a pandemic is crucial. In addition to the fact that pregnancy is a risk factor for severe COVID-19 and that medical surveillance has to be adjusted in infected women and their offspring, knowledge about infect...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837405/ https://www.ncbi.nlm.nih.gov/pubmed/35169390 http://dx.doi.org/10.1055/a-1727-9672 |
_version_ | 1784649901918912512 |
---|---|
author | Hein, Alexander Kehl, Sven Häberle, Lothar Tiemann, Carsten Peuker, Rebecca Mereutanu, Denise Stumpfe, Florian M. Faschingbauer, Florian Meyer-Schlinkmann, Kirstin Koch, Martin C. Kainer, Franz Dammer, Ulf Philipp, Hanna Kladt, Carolin Schrauder, Michael G. Weingärtler, Stefan Hanf, Volker Hartmann, Arndt Rübner, Matthias Schneider, Holm Lelieveld, Jos Beckmann, Matthias W. Wurmthaler, Lena A. Fasching, Peter A. Schneider, Michael O. |
author_facet | Hein, Alexander Kehl, Sven Häberle, Lothar Tiemann, Carsten Peuker, Rebecca Mereutanu, Denise Stumpfe, Florian M. Faschingbauer, Florian Meyer-Schlinkmann, Kirstin Koch, Martin C. Kainer, Franz Dammer, Ulf Philipp, Hanna Kladt, Carolin Schrauder, Michael G. Weingärtler, Stefan Hanf, Volker Hartmann, Arndt Rübner, Matthias Schneider, Holm Lelieveld, Jos Beckmann, Matthias W. Wurmthaler, Lena A. Fasching, Peter A. Schneider, Michael O. |
author_sort | Hein, Alexander |
collection | PubMed |
description | Purpose Detection of SARS-CoV-2-infected pregnant women admitted to maternity units during a pandemic is crucial. In addition to the fact that pregnancy is a risk factor for severe COVID-19 and that medical surveillance has to be adjusted in infected women and their offspring, knowledge about infection status can provide the opportunity to protect other patients and healthcare workers against virus transmission. The aim of this prospective observational study was to determine the prevalence of SARS-CoV-2 infection among pregnant women in the hospital setting. Material and Methods All eligible pregnant women admitted to the nine participating hospitals in Franconia, Germany, from 2 June 2020 to 24 January 2021 were included. COVID-19-related symptoms, secondary diseases and pregnancy abnormalities were documented. SARS-CoV-2 RNA was detected by RT-PCR from nasopharyngeal swabs. The prevalence of acute SARS-CoV-2 infection was estimated by correcting the positive rate using the Rogan–Gladen method. The risk of infection for healthcare workers during delivery was estimated using a risk calculator. Results Of 2414 recruited pregnant women, six were newly diagnosed RT-PCR positive for SARS-CoV-2, which yielded a prevalence of SARS-CoV-2 infection of 0.26% (95% CI, 0.10 – 0.57%). Combining active room ventilation and wearing FFP2 masks showed an estimated reduction of risk of infection for healthcare workers in the delivery room to < 1%. Conclusions The prevalence of newly diagnosed SARS-CoV-2 infection during pregnancy in this study is low. Nevertheless, a systematic screening in maternity units during pandemic situations is important to adjust hygienic and medical management. An adequate hygienic setting can minimise the calculated infection risk for medical healthcare workers during patientsʼ labour. |
format | Online Article Text |
id | pubmed-8837405 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Georg Thieme Verlag KG |
record_format | MEDLINE/PubMed |
spelling | pubmed-88374052022-02-14 Prevalence of SARS-CoV-2 in Pregnant Women Assessed by RT-PCR in Franconia, Germany: First Results of the SCENARIO Study (SARS-CoV-2 prEvalence in pregNAncy and at biRth In FrancOnia) Hein, Alexander Kehl, Sven Häberle, Lothar Tiemann, Carsten Peuker, Rebecca Mereutanu, Denise Stumpfe, Florian M. Faschingbauer, Florian Meyer-Schlinkmann, Kirstin Koch, Martin C. Kainer, Franz Dammer, Ulf Philipp, Hanna Kladt, Carolin Schrauder, Michael G. Weingärtler, Stefan Hanf, Volker Hartmann, Arndt Rübner, Matthias Schneider, Holm Lelieveld, Jos Beckmann, Matthias W. Wurmthaler, Lena A. Fasching, Peter A. Schneider, Michael O. Geburtshilfe Frauenheilkd Purpose Detection of SARS-CoV-2-infected pregnant women admitted to maternity units during a pandemic is crucial. In addition to the fact that pregnancy is a risk factor for severe COVID-19 and that medical surveillance has to be adjusted in infected women and their offspring, knowledge about infection status can provide the opportunity to protect other patients and healthcare workers against virus transmission. The aim of this prospective observational study was to determine the prevalence of SARS-CoV-2 infection among pregnant women in the hospital setting. Material and Methods All eligible pregnant women admitted to the nine participating hospitals in Franconia, Germany, from 2 June 2020 to 24 January 2021 were included. COVID-19-related symptoms, secondary diseases and pregnancy abnormalities were documented. SARS-CoV-2 RNA was detected by RT-PCR from nasopharyngeal swabs. The prevalence of acute SARS-CoV-2 infection was estimated by correcting the positive rate using the Rogan–Gladen method. The risk of infection for healthcare workers during delivery was estimated using a risk calculator. Results Of 2414 recruited pregnant women, six were newly diagnosed RT-PCR positive for SARS-CoV-2, which yielded a prevalence of SARS-CoV-2 infection of 0.26% (95% CI, 0.10 – 0.57%). Combining active room ventilation and wearing FFP2 masks showed an estimated reduction of risk of infection for healthcare workers in the delivery room to < 1%. Conclusions The prevalence of newly diagnosed SARS-CoV-2 infection during pregnancy in this study is low. Nevertheless, a systematic screening in maternity units during pandemic situations is important to adjust hygienic and medical management. An adequate hygienic setting can minimise the calculated infection risk for medical healthcare workers during patientsʼ labour. Georg Thieme Verlag KG 2022-02-11 /pmc/articles/PMC8837405/ /pubmed/35169390 http://dx.doi.org/10.1055/a-1727-9672 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited. |
spellingShingle | Hein, Alexander Kehl, Sven Häberle, Lothar Tiemann, Carsten Peuker, Rebecca Mereutanu, Denise Stumpfe, Florian M. Faschingbauer, Florian Meyer-Schlinkmann, Kirstin Koch, Martin C. Kainer, Franz Dammer, Ulf Philipp, Hanna Kladt, Carolin Schrauder, Michael G. Weingärtler, Stefan Hanf, Volker Hartmann, Arndt Rübner, Matthias Schneider, Holm Lelieveld, Jos Beckmann, Matthias W. Wurmthaler, Lena A. Fasching, Peter A. Schneider, Michael O. Prevalence of SARS-CoV-2 in Pregnant Women Assessed by RT-PCR in Franconia, Germany: First Results of the SCENARIO Study (SARS-CoV-2 prEvalence in pregNAncy and at biRth In FrancOnia) |
title | Prevalence of SARS-CoV-2 in Pregnant Women Assessed by RT-PCR in Franconia, Germany: First Results of the SCENARIO Study (SARS-CoV-2 prEvalence in pregNAncy and at biRth In
FrancOnia) |
title_full | Prevalence of SARS-CoV-2 in Pregnant Women Assessed by RT-PCR in Franconia, Germany: First Results of the SCENARIO Study (SARS-CoV-2 prEvalence in pregNAncy and at biRth In
FrancOnia) |
title_fullStr | Prevalence of SARS-CoV-2 in Pregnant Women Assessed by RT-PCR in Franconia, Germany: First Results of the SCENARIO Study (SARS-CoV-2 prEvalence in pregNAncy and at biRth In
FrancOnia) |
title_full_unstemmed | Prevalence of SARS-CoV-2 in Pregnant Women Assessed by RT-PCR in Franconia, Germany: First Results of the SCENARIO Study (SARS-CoV-2 prEvalence in pregNAncy and at biRth In
FrancOnia) |
title_short | Prevalence of SARS-CoV-2 in Pregnant Women Assessed by RT-PCR in Franconia, Germany: First Results of the SCENARIO Study (SARS-CoV-2 prEvalence in pregNAncy and at biRth In
FrancOnia) |
title_sort | prevalence of sars-cov-2 in pregnant women assessed by rt-pcr in franconia, germany: first results of the scenario study (sars-cov-2 prevalence in pregnancy and at birth in
franconia) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837405/ https://www.ncbi.nlm.nih.gov/pubmed/35169390 http://dx.doi.org/10.1055/a-1727-9672 |
work_keys_str_mv | AT heinalexander prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia AT kehlsven prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia AT haberlelothar prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia AT tiemanncarsten prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia AT peukerrebecca prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia AT mereutanudenise prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia AT stumpfeflorianm prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia AT faschingbauerflorian prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia AT meyerschlinkmannkirstin prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia AT kochmartinc prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia AT kainerfranz prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia AT dammerulf prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia AT philipphanna prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia AT kladtcarolin prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia AT schraudermichaelg prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia AT weingartlerstefan prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia AT hanfvolker prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia AT hartmannarndt prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia AT rubnermatthias prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia AT schneiderholm prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia AT lelieveldjos prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia AT beckmannmatthiasw prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia AT wurmthalerlenaa prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia AT faschingpetera prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia AT schneidermichaelo prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia |